Fei Sun
Impact in
-
- Cancer, Hypoxia, and Metabolism
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
-
- Metabolomics and Mass Spectrometry Studies
- Circular RNAs in diseases
- Ubiquitin and proteasome pathways
Papers in
-
- Metabolomics and Mass Spectrometry Studies 2
- Circular RNAs in diseases 2
-
- Cancer-related molecular mechanisms research 2
- Co-authors
- Zeping Hu (3 shared papers)Hongbo Wang (1 shared paper)Tongdan Jin (4 shared papers)Ke Yao (1 shared paper)Xiangjun Meng (1 shared paper)Bohong Wang (1 shared paper)Huanhuan Pang (1 shared paper)Xiaohan Jin (1 shared paper)
- Journals
- Nature Communications (1 paper)Biochemical and Biophysical Research Communications (1 paper)Medicine (1 paper)American Journal of Translational Research (1 paper)Clinical Rheumatology (1 paper)
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Fei Sun
28 papers receiving 405 citations
Peers
Comparison fields: 5 of 91
- Cancer Research 103
- Molecular Biology 201
- Spectroscopy 44
- Biochemistry 14
- Clinical Biochemistry 11
Countries citing papers authored by Fei Sun
This map shows the geographic impact of Fei Sun's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fei Sun with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fei Sun more than expected).
Fields of papers citing papers by Fei Sun
This network shows the impact of papers produced by Fei Sun. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fei Sun. The network helps show where Fei Sun may publish in the future.
Co-authors
The 25 scholars most cited alongside Fei Sun, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 30 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 70 | |
| 2 | 2021 | 69 | |
| 3 | 2022 | 55 | |
| 4 | 2022 | 26 | |
| 5 | 2019 | 26 | |
| 6 | 2020 | 19 | |
| 7 | 2021 | 18 | |
| 8 | 2011 | 18 | |
| 9 | 2021 | 13 | |
| 10 | Expression profile of long noncoding RNAs in children with systemic lupus erythematosus: a microarray analysis. | 2019 | 13 |
| 11 | 2018 | 12 | |
| 12 | KIF22 promotes progress of esophageal squamous cell carcinoma cells and is negatively regulated by miR-122. | 2021 | 11 |
| 13 | 2020 | 9 | |
| 14 | 2024 | 9 | |
| 15 | 2020 | 7 | |
| 16 | 2020 | 6 | |
| 17 | 2021 | 5 | |
| 18 | 2022 | 4 | |
| 19 | 2000 | 3 | |
| 20 | 2018 | 3 |
About Fei Sun
Fei Sun is a scholar working on Molecular Biology, Cancer Research, Electrical and Electronic Engineering, Control and Systems Engineering and Pulmonary and Respiratory Medicine, having authored 30 papers that have together received 407 indexed citations. Recurring topics across this work include interferon and immune responses (2 papers), Metabolomics and Mass Spectrometry Studies (2 papers), Smart Grid Energy Management (2 papers), Cancer-related molecular mechanisms research (2 papers), Microgrid Control and Optimization (2 papers), Digital Transformation in Industry (2 papers), Circular RNAs in diseases (2 papers) and Cancer-related Molecular Pathways (2 papers). The work is most often cited by research in Cancer Research (103 citations), Molecular Biology (201 citations), Spectroscopy (44 citations), Biochemistry (14 citations) and Clinical Biochemistry (11 citations). Fei Sun has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Zeping Hu, Hongbo Wang, Tongdan Jin, Ke Yao, Xiangjun Meng, Bohong Wang, Huanhuan Pang, Xiaohan Jin, LiAng Yao and Lijuan Wang. Their work appears in journals such as Nature Communications, Biochemical and Biophysical Research Communications, Medicine, American Journal of Translational Research and Clinical Rheumatology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.